• Explore /
  • Poster
  • / Demographics and treatment outcomes in patients with EBV<sup>+</sup> PTLD treated with off-the-shelf EBV-specific CTL under an ongoing expanded access program in Europe: First analyses.

Demographics and treatment outcomes in patients with EBV+ PTLD treated with off-the-shelf EBV-specific CTL under an ongoing expanded access program in Europe: First analyses.

Abstract Poster

Authors

Sylvain Choquet

Sylvain Choquet

Hôpital de la Pitié-Salpêtrière, Paris, France

Sylvain Choquet , Sridhar Chaganti , Ben Uttenthal , Patrizia Comoli , Ralf Ulrich Trappe , Anke Friedetzky , Baodong Xing , Xiaoming Li , Tobias Boy Polak , Laurence Gamelin , Jan-Henrik Terwey , Daan Dierickx

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Track

Hematologic Malignancies

Sub Track

Cell Therapy, Bispecific Antibodies, and Autologous Stem Cell Transplantation for NHL, HL, or CLL

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 7530)

DOI

10.1200/JCO.2022.40.16_suppl.7530

Abstract #

7530

Poster Bd #

184

Abstract Disclosures

Similar Posters

First Author: Jennifer Ann Kanakry

First Author: Sylvain Choquet

First Author: Daniel S. Heil

First Author: Scott J. Keating